FDA Inspection 1051475 — Beacon Kalamazoo
The FDA completed an inspection of Beacon Kalamazoo on Mar 2, 2018 in Kalamazoo, MI. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 2, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Kalamazoo, MI (United States)